Online citations, reference lists, and bibliographies.
← Back to Search

Cationic Vectors In Ocular Drug Delivery

L. Rabinovich-Guilatt, P. Couvreur, G. Lambert, C. Dubernet
Published 2004 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Despite extensive research in the field, the major problem in the ocular drug delivery domain still is rapid precorneal drug loss and poor corneal permeability. One of the approaches recently developed is the drug incorporation into cationic submicronic vectors which exploit the negative charges present at the corneal surface for increased residence time and penetration. This review will focus on the formulation of three main representative cationic colloids developed for ophthalmic delivery: liposomes, emulsions and nanoparticles (NP). Parameters such as choice of the vector type and size, nature of the cationic molecule, pH and ionic strength of the external phase and characteristics of the encapsulated drug will be discussed with accent on the relevance of the positive charge.
This paper references
10.1016/0378-5173(92)90353-4
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
C. Lehr (1992)
10.1002/JPS.2600721108
Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors
Hong-Shian Huang (1983)
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
I. Ahmed (1985)
Uptake of Bioadhesive Nanoparticles in a Normal Human Conjunctiva (NHC) Epithelial Cell Line
Y. Diebold (2003)
10.3109/02713688509025154
Ocular pharmacology of sulfonamides: the cornea as barrier and depot.
T. Maren (1985)
10.1016/0378-5173(89)90334-7
Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes
R. Diepold (1989)
10.1111/j.2042-7158.1986.tb04611.x
A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man
I. Zaki (1986)
10.1016/S0928-0987(03)00178-7
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
A. M. de Campos (2003)
10.1023/A:1013061926851
Predicted Permeability of the Cornea to Topical Drugs
A. Edwards (2004)
10.1023/A:1015810619869
Formulation Influence on Conjunctival Penetration of Four Beta Blockers in the Pigmented Rabbit: A Comparison with Corneal Penetration
P. Ashton (2004)
10.1016/S0378-5173(97)00083-5
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
10.1016/S0378-5173(99)00003-4
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.
O. Felt (1999)
10.1016/S0142-9612(02)00080-7
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
R. Pignatello (2002)
Human tear responses to alkali.
R. Hill (1980)
10.1016/S0378-5173(99)00265-3
Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery.
M. Nagarsenker (1999)
10.1002/jps.2600650909
Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.
T. Patton (1976)
10.1016/0378-5173(91)90241-F
Permeability of pilocarpic acid diesters across albino rabbit cornea in vitro
P. Suhonen (1991)
Human tear responses to alkali”, Investig
R. M. Hill (1980)
10.1002/JPS.2600651123
Effect of topically applied pilocarpine on tear film pH.
A. Longwell (1976)
10.1081/PDT-100102035
Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution
S. Klang (2000)
10.3109/02652049109021873
Studies on the transport pathway of PBCA nanoparticles in ocular tissues.
A. Zimmer (1991)
10.1016/S0378-5173(97)04876-X
Influence of pH and buffer concentration on the ocular bioavailability of ophthalmic AGN 191103 formulations in albino rabbits
D. Small (1997)
10.1111/j.2042-7158.1987.tb03428.x
A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit
P. Fitzgerald (1987)
10.1016/S0003-9861(02)00725-7
Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization.
Mohamad Radwan Almofti (2003)
Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
K. M. Hämäläinen (1997)
Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.
R. Schoenwald (1983)
10.1023/A:1020404615898
Uptake of FITC-Chitosan Nanoparticles by A549 Cells
M. Huang (2004)
10.1002/JPS.2600721109
Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions.
H. Huang (1983)
10.1002/JPS.2600620712
Lacrimal and instilled fluid dynamics in rabbit eyes.
S. Chrai (1973)
10.3109/02713689008997579
Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.
D. Chien (1990)
Liposomes in topical drug delivery.
H. E. Schaeffer (1982)
10.1016/S0014-4835(05)80041-7
Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor.
C. W. Conroy (1995)
10.1016/0378-5173(84)90164-9
Effect of pH and buffer on the precorneal disposition and ocular penetration of pilocarpine in rabbits
I. Ahmed (1984)
10.1080/026520499289211
Ocular drug targeting by liposomes and their corneal interactions.
T. Velpandian (1999)
10.1002/JPS.2600670614
Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients.
R. Schoenwald (1978)
10.1076/CEYR.17.10.1005.5239
Fluorophotometric measurement of the buffering action of human tears in vivo.
M. Yamada (1998)
10.1016/0378-5173(89)90030-6
Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine
D. Meisner (1989)
10.1016/S0168-3659(98)00107-2
Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn.
S. Klang (1999)
10.1016/J.CHEMPHYSLIP.2004.04.003
Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions.
L. Rabinovich-Guilatt (2004)
Ocular anatomy and physiology relevant to ocular drug delivery
J. C. Robinson (1993)
Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
Mohamed G. Qaddoumi (2003)
10.1016/S0168-3659(99)00192-3
Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
S. Law (2000)
10.1016/0169-409X(95)00016-Z
Liposome ocular delivery systems
D. Meisner (1995)
Buffering in human tears: pH responses to acid and base challenge.
L. Carney (1989)
10.1021/JS950474+
Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
P. Calvo (1996)
10.1016/S1461-5347(98)00087-X
RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY
Shulin Ding (1998)
10.1016/S0378-5173(97)00186-5
Preparation and evaluation of acetazolamide liposomes as an ocular delivery system
O. El-Gazayerly (1997)
10.1248/BPB1978.11.607
Assessment of ocular irritability of liposome preparations.
K. Taniguchi (1988)
10.1111/j.2042-7158.1996.tb03911.x
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
P. Calvo (1996)
10.1016/0378-5173(92)90308-O
The effect of drug charge type and charge density on corneal transport
J. Liaw (1992)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1016/S0005-2736(00)00342-4
Kinetic analysis of the initial steps involved in lipoplex--cell interactions: effect of various factors that influence transfection activity.
M. D. da Cruz (2001)
10.3109/02652049309015310
Liposomal drug delivery to the eye and lungs: a preliminary electron microscopy study.
M. Singh (1993)
10.1016/S0168-3659(96)01503-9
Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea
S. Muchtar (1997)
10.1023/A:1019854327540
Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport
I. Behrens (2004)
10.1016/0378-5173(89)90047-1
Transport mechanisms of the cornea: characterization of barrier permselectivity
Y. Rojanasakul (1989)
10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
10.1002/JPS.2600760802
Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.
I. Ahmed (1987)
10.1111/j.2042-7158.1994.tb03254.x
Physicochemical Characterization and Acute Toxicity Evaluation of a Positively‐charged Submicron Emulsion Vehicle
S. Klang (1994)
10.1016/S0928-0987(02)00057-X
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
R. Pignatello (2002)
10.1006/EXER.1998.0600
Physical properties of stimulated and unstimulated tears.
J. Pandit (1999)
10.1016/0378-5173(94)90179-1
Study of the mechanism of interaction of poly(ϵ-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy
P. Calvo (1994)
10.1016/J.IJPHARM.2003.09.016
Vesicular systems in ocular drug delivery: an overview.
I. P. Kaur (2004)
10.1016/S0031-6865(97)00021-6
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations.
V. Baeyens (1997)
Ocular delivery of cyclosporin A. II. Effect of submicron emulsion's surface charge on ocular distribution of topical cyclosporin A
M. Abdulrazik (2001)
10.1007/978-1-4615-2417-5_40
Composition and biophysical properties of the tear film: knowledge and uncertainty.
J. Tiffany (1994)



This paper is referenced by
10.1016/J.MSEC.2019.109883
Surface potential and charges impact on cell responses on biomaterials interfaces for medical applications.
Sara Metwally (2019)
Nanoparticulate Drug Delivery Systems
Jaya Raja Kumar Kalaimani (2016)
Desarrollo de un nuevo tratamiento para el ojo seco basado en la terapia génica con sistemas nanoparticulares
G. K. Zorzi (2011)
A bioresponsive polymeric implant for site-specific prolonged drug delivery
D. Toit (2014)
10.3109/03639045.2015.1118497
In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects
Mária Budai-Szű cs (2016)
10.1016/B978-0-444-63285-2.00004-3
Derivatization of Colloidal Gold Nanoparticles Toward Their Application in Life Sciences
Dominik Hühn (2014)
10.1002/9783527610419.NTLS0115
Polymeric Nanoparticles for Drug Delivery
P. Kallinteri (2007)
10.1007/978-81-322-1689-6_10
Nanoparticulate Delivery Systems
A. De (2014)
10.1007/978-1-4614-9524-6_9
Ocular Delivery of Biopharmaceuticals
H. Lorentz (2014)
10.1016/S1773-2247(13)50016-5
Nano and microtechnologies for ophthalmic administration, an overview
R. Herrero-Vanrell (2013)
10.2147/IJN.S77837
Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA
Z. Shao (2015)
Nanoemulsions for drug delivery through different routes
U. Prakash (2011)
10.1586/17469899.3.3.325
When nanotechnology meets the ocular surface
C. Bucolo (2008)
10.1016/S1003-6326(15)63629-9
Arginine functionalized hydroxyapatite nanoparticles and its bioactivity for gene delivery
Guohui Wang (2015)
10.5772/INTECHOPEN.71062
Gene Delivery by Hydroxyapatite and Calcium Phosphate Nanoparticles: A Review of Novel and Recent Applications
F. Bakan (2017)
10.1016/J.IJPHARM.2009.01.001
Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect.
J. Zhang (2009)
10.2147/OPTH.S75297
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
G. Ousler (2015)
10.1016/j.omtn.2019.07.017
Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide
D. Schiroli (2019)
Recent Drug Delivery Systems for Treatment of Glaucoma
Noha S El-Salamounia (2016)
10.1002/APP.34323
Chitosan as an ocular drug delivery vehicle for vancomycin
A. Khangtragool (2011)
10.1007/978-1-4614-9524-6_24
Development of a Cationic Nanoemulsion Platform (Novasorb®) for Ocular Delivery
F. Lallemand (2014)
10.1155/2012/604204
Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb
F. Lallemand (2012)
10.1016/j.colsurfb.2009.06.021
Surface active properties of chitosan and its derivatives.
M. Elsabee (2009)
10.1016/J.IJPHARM.2006.02.050
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity.
R. Cortesi (2006)
10.1002/mabi.201100005
Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy.
G. K. Zorzi (2011)
10.1208/s12248-010-9183-3
Ocular Drug Delivery
Ripal Gaudana (2010)
Investigations into drug delivery to the eye : nanoparticle comparisons
Yousef Al-Ebini (2014)
10.1021/nn3059295
Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge.
Dominik Hühn (2013)
10.1016/j.exer.2014.02.001
Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus.
N. Elsaid (2014)
10.1016/j.ijpharm.2011.02.020
Ciprofloxacin surf-plexes in sub-micron emulsions: a novel approach to improve payload efficiency and antimicrobial efficacy.
Vikas Jain (2011)
10.1201/9781420008449.CH16
Ocular Applications of Nanoparticulate Drug-Delivery Systems
A. Ludwig (2007)
10.1016/j.jconrel.2015.01.022
Bispecific single-chain diabody-immunoliposomes targeting endoglin (CD105) and fibroblast activation protein (FAP) simultaneously.
Markus Rabenhold (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar